In This Section

Program: Monday, October 19

Please note that this meeting will take place as an in-person event in Atlanta and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Sunday, Oct. 18 Tuesday, Oct. 20 Wednesday, Oct. 21

Monday, October 19

Monday, October 19

Breakfast and Networking Roundtables

8-9 a.m.

Plenary Session 1: Artificial Intelligence in Cancer Disparities: Opportunities and Challenges

9-10:30 a.m.

Session Chair: Enrique Velazquez Villarreal, City of Hope National Medical Center, Duarte, California and Mukesh Verma, National Cancer Institute, Rockville, Maryland

  • 9:05 a.m. | Andre Pfob, Heidelberg University Hospital, Heidelberg , Germany
  • 9:20 a.m. | Enrique Velazquez Villarreal, City of Hope National Medical Center, Duarte, California
  • 9:35 a.m. | Gabriel Benavidez, Baylor University, Waco, Texas
  • 9:50 a.m. | Mukesh Verma, National Cancer Institute, Rockville, Maryland
  • 10:05 a.m. | Panel Discussion and Q&A
    Additional Panelist:
    Ysabel Duron, The Latino Cancer Institute, San Jose, California

Break

10:30-11 a.m.

Special Session: Advancing Translational Research in Cancer Health Disparities

Organized by the NCI U54 Cancer Health Disparities SPORE Program

11 a.m.-12 p.m.

Session Chairs: Susan Chang, University of California San Francisco, San Francisco, California and Leah Hubbard, National Institutes of Health, Bethesda, Maryland

  • 11 a.m. | Overview of NCI SPORE Cancer Health Disparities Translational Research Program
    Leah Hubbard, National Institutes of Health, Bethesda, Maryland
    Tiffany A. Wallace, NCI-CRCHD, Rockville, Maryland
  • 11:06 a.m. | Translating genomic and environmental data into risk-stratified colorectal cancer screening for diverse populations
    Riki (Ulrike) Peters, Fred Hutchinson Cancer Center, Seattle, Washington
  • 11:18 a.m. | AI-powered radiomics resolves the inaccuracy in breast cancer risk assessment in Asian subgroups compared to clinical models
    Lenora W. M. Loo, University of Hawai’i Cancer Center, Honolulu, Hawaii
  • 11:30 a.m. | Obesity-related metabolic reprogramming in endometrial cancer disparities
    Melinda S. Yates, UNC School of Medicine, Chapel Hill, North Carolina
  • 11:42 a.m. | Panel Discussion and Q&A

Lunch on own

12-2 p.m.

Professional Advancement for Cancer Disparities Researchers

Organized by the AACR Minorities in Cancer Research Council

12-2 p.m.

Plenary Session 2: The Promise of GLP-1s in Cancer Risk Reduction

2-3:30 p.m.

Session Chair: Tiffany Carson, H. Lee Moffitt Cancer Center, Tampa, Florida

  • 2:05 p.m. | GLP-1 agonists in cancer prevention: Current evidence and future directions
    Florence Porterfield, Massachusetts General Hospital, Boston, Massachusetts
  • 2:25 p.m. | GLP-1 receptor agonist use and survival and recurrence in breast cancer
    Kristina Tatum, VCU Massey Comprehensive Cancer Center, Richmond, Virginia
  • 2:45 p.m. | Cleo Ryals, Flatiron Health, New York, New York
  • 3:05 p.m. | Panel Discussion and Q&A

Break

3:30-3:45 p.m.

CONCURRENT SESSIONS 1 AND 2

3:45-4:45 p.m.

CONCURRENT SESSION 1: Ethnic Enclaves, Ethnoburbs, or Residential Segregation? How Coethnic Neighborhood Context Shapes Cancer Disparities

Session Chair: Kevin A. Henry, Temple University, Philadelphia, Pennsylvania

  • 3:50 p.m. | Salma Shariff-Marco, University of California San Francisco, San Francisco, California
  • 4:05 p.m. | Using cancer registry data to examine geographic disparities in cancer outcomes across ethnic enclaves in New York City
    Daniel Wiese, American Cancer Society, Atlanta, Georgia
  • 4:20 p.m. | Marilyn Tseng, Cal Poly, San Luis Obispo, California
  • 4:35 p.m. | Panel Discussion and Q&A
    Additional Panelist:
    Keeshia Jones, After Breast Cancer Diagnosis, Milwaukee, Wisconsin

Concurrent Session 2: Designing Global Cancer Disparities Research for Impact: Building Collaborations That Translate, Scale, and Endure

Session Chairs : Adana A. M. Llanos, Columbia University Mailman School of Public Health, New York, New York and Camille Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania

  • 3:50 p.m. | Folakemi T. Odedina, Mayo Clinic Florida, Jacksonville, Florida
  • 4 p.m. | Implementation and systems translation: Building research capacity and scientific infrastructure for cancer disparities in Kenya
    Rahma Mkuu, University of Florida, Gainesville, Florida
  • 4:10 p.m. | Valerie Odero-Marah, Morgan State University, Baltimore, Maryland
  • 4:20 p.m. | Creating patient centricity in clinical cancer research
    Virgil Simons, The Prostate Net, Hackensack, New Jersey
  • 4:35 p.m. | Panel Discussion and Q&A

Break

4:45–5 p.m.

Special Session 2: Charting the Path Forward: Lessons and Next Steps from the AACR Cancer Disparities Progress Report

5-6:15 p.m.

Moderator: Mariana Stern, USC Norris Comprehensive Cancer Center, Los Angeles, California

  • 5 p.m. | Introduction
    Keith T. Flaherty, Mass General Cancer Center, Boston, Massachusetts
  • 5:05 p.m. | Mariana Stern, USC Norris Comprehensive Cancer Center, Los Angeles, California
  • 5:20 p.m. | John M. Carethers, UCSD Medical Center, San Diego, California
  • 5:25 p.m. | Iona C. Cheng, University of California San Francisco, San Francisco, California
  • 5:30 p.m. | Carmen E. Guerra, University of Pennsylvania, Philadelphia, Pennsylvania
  • 5:35 p.m. | Rhonda Holbert, Celebrate Life Cancer Ministry, Hawthorne, California
  • 5:40 p.m. | Keith T. Flaherty, Mass General Cancer Center, Boston, Massachusetts
  • 5:45 p.m. | Robert A. Winn, Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • 5:50 p.m. | Panel Discussion: Future Directions
Read the AACR Cancer Disparities Progress Report

Poster Spotlight Presentations 1 and 2

6:30-7 p.m.

Poster Spotlight Presentations 1

  • 6:30 p.m. | Reference genome selection as a determinant of genomic variation recovery in admixed populations: A comparative framework for ancestry-informed inquiry
    Praise Idowu, Morehouse School of Medicine, Atlanta, Georgia
  • 6:33 p.m. | Genetic similarity, duffy-null genotype, and autologous transplant in multiple myeloma: Disparities in depth of response but not survival
    Ayo S. Falade, Mayo Clinic, Rochester, Minnesota
  • 6:36 p.m. | Evaluating fairness in breast cancer risk prediction by race using the adjusted true positive rate in a digital breast tomosynthesis screening cohort
    Lindsey Abellard, University of Pennsylvania, Philadelphia, Pennsylvania
  • 6:39 p.m. | Racial and ethnic disparities in the risk of contralateral breast cancer among primary breast cancer survivors in the US (1992-2023)
    Michelle O. Sodipo, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • 6:42 p.m. | The missing majority: Older adults and age-based disparities in cancer research reporting
    Adrian Puello, Centre Hospitalier Universitaire de la Martinique, Fort de France, France
  • 6:45 p.m. | Bridging the gap: The impact of health policy on breast cancer disparities in underserved communities
    Lashelle Scott, Independent Researcher, Houston, Texas
  • 6:48 p.m. | Patterns of physiological dysregulation and cancer mortality: A latent class analysis of NHANES participants
    Terry Hyslop, Sidney Kimmel Comprehensive Cancer Center, Philadelphia, Pennsylvania
  • 6:51 p.m. | Age-related differences in clinician communication about colorectal cancer screening in the US
    Jordan Baeker Bispo, American Cancer Society, Atlanta, Georgia
  • 6:54 p.m. | Landscape of genetic ancestry-associated active drugs unique to or shared by White and Hispanic children with group 3 medulloblastomas
    Jinnan Chen, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois

Poster Spotlight Presentations 2

  • 6:30 p.m. | Germline variation in cancer susceptibility genes among Black cancer survivors in the Reclassifying Variants for Equity in Clinical Care (REVEAL) study
    Savannah Lane, Wayne State University, Detroit, Michigan
  • 6:33 p.m. | Neighborhood environmental exposures are associated with tumor genomic alterations and clinical outcomes across cancers
    Jiawei Tu, UTHealth Houston, Houston, Texas
  • 6:36 p.m. | Association of social determinants of health and metabolic comorbidities with cervical cancer risk and disparities
    Jenae Sanders, Morehouse School of Medicine, Atlanta, Georgia
  • 6:39 p.m. | Genome and Transcriptome-Wide Association Studies of HER2-positive breast cancer in Hispanic/Latina women in the United States and women in Latin America
    Joel Sanchez Mendez, University of California Davis, Davis, California
  • 6:42 p.m. | Redlining, gentrification, and the relationship to diagnosis of prostate cancer at midlife
    Charnita Zeigler-Johnson, Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • 6:45 p.m. | Neighborhood deprivation and the breast tumor transcriptome: Distinct associations by race and estrogen receptor status
    Jasmine Miller-Kleinhenz, University of Mississippi Medical Center, Jackson, Mississippi
  • 6:48 p.m. | Interstate travel, travel time, and access barriers in pediatric oncology care across the United States
    Erin L. Marcotte, University of Minnesota, Minneapolis, Minnesota
  • 6:51 p.m. |  A community health assessment to inform cervical cancer prevention and reduce disparities in the Tri-County region of Illinois
    Lauren Giurini, University of Illinois Chicago, Chicago, Illinois
  • 6:54 p.m. |  An explainable and multiethnic deep learning platform for melanoma screening and diagnosis using the ABCDE rule and two-dimensional full-body sequential analysis
    Kevin D. Cassel, University of Hawaiʻi Cancer Center, Honolulu, Hawaii
  • 6:57 p.m. | Navigator-led patient outreach to improve lung cancer screening completion in a primary care setting in San Antonio
    Moushumi Sahu, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Poster Session B and Reception

7-8:30 p.m.